The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder

Overview

To assess wether methylphenidate reduces the prevalence of primary nocturnal enuresis in children with attention deficit disorder

Full Title of Study: “Does Methylphenidate, Prescribed for Attention Deficit Disorder, Influence Primary Enuresis in These Children?”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: April 2017

Detailed Description

Children aged 5 – 10 years newly diagnosed with attention deficit hyperactivity disorder who report primary nocturnal enuresis, Investigators will obtain baseline data (from parents/caregivers) on their sleep habits and enuresis characteristics by questionnaire. After 6 weeks of methylphenidate therapy, prescribed for the attention deficit, a new questionnaire will be filled.

Interventions

  • Drug: methylphenidate
    • The drug will be prescribed as indicated for attention deficit disorder

Clinical Trial Outcome Measures

Primary Measures

  • A reduction in nocturnal enuresis frequency
    • Time Frame: 6 weeks

Participating in This Clinical Trial

Inclusion Criteria

  • New diagnosis of attention deficit hyperactivity disorder – History of primary nocturnal enuresis – Normal neurological examination Exclusion Criteria:

  • Anatomical abnormality of the genitourinary system – Concommitant treatment, pharmacological/behavioral for enuresis – Concommitant diurnal enuresis

Gender Eligibility: All

Minimum Age: 5 Years

Maximum Age: 10 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Meir Medical Center
  • Provider of Information About this Clinical Study
    • Principal Investigator: Natan Watemberg, MD – Meir Medical Center
  • Overall Official(s)
    • Nathan Watemberg, MD, Principal Investigator, Meir Medical Center
  • Overall Contact(s)
    • Florence Katz, BA, 972-9-7471803, florence.katz@clalit.org.il

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.